Please login or register first to view this content.
ECTRIMS 2018
ECTRIMS 2018
Glatiramer Acetate Associated With Long-Term Disability Improvements in MS
Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
High-Dose Biotin May Be an Effective Treatment for Progressive MS
MS Relapse Rates After DMT Initiation Similar Between Pediatric-, Adult-Onset MS
Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
Disease Modifying Therapy Associated With Persistent Brain Atrophy Slowing in MS
Patients With Multiple Sclerosis Face Greater Infection Risk
Alemtuzumab Improves Disability, Prognosis in Treatment-Refractory MS
Sexual Dysfunction Prevalent but Underrecognized in Multiple Sclerosis
Want to read more?
Next post in ECTRIMS 2018
